Reference
- SEER Stat Fact Sheets. Accessible at http://seer.cancer.gov/statfacts/html/colorect.html. Accessed June 19, 2009
- Benson A. Epidemiology, disease progression and economic burden of colorectal cancer. J Manag Care Pharm 2007;1:S5-18
- Ramsey S, Berry K, Etzioni R. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol 2002;97:440-445
- Etzioni R, Ramsey S, Berry K, et al. The impact of including future medical costs when estimating the costs attributable to a disease: a colorectal cancer case study. J Health Econ 2001;10:245-256
- Paramore C, Thomas S, Knopf K, et al. Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 2006;6:52-58
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-Cm administrative databases. J Clin Epidemiol 1992;45:613-619
- Rao S, Kubisiak J, Gilden D. Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat 2004;83:25-32
- Joyce AT, Iacoviello JM, Nag S, et al. End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care 2004;27:2829-2835
- Etzioni RD, Feuer EJ, Sullivan SD, et al. On the use of survival analysis techniques to estimate medical care costs. J Health Econ 1999;18:365-380
- Lin DY, Feuer EJ, Etzioni R, et al. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-434
- Wong Y, Meropol NJ, Speier W, et al. Cost implications of new treatments for advanced colorectal cancer. Cancer 2009;115:2081-2091
- Howard DH, Kauh J, Lipscomb J. The value of new chemotherapeutic agents for metastatic colorectal cancer. Arch Intern Med 2010;170:537-542
- Tappenden P, Jones R, Paisley S, et al. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. Health Technol Assess 2007;11:1-128, iii-iv
- Ferro SA, Myer BS, Wolff DA, et al. Variation in the cost of medications for the treatment of colorectal cancer. Am J Manag Care 2008;14:717-725
- Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999;16:1-8